NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Royalty Pharma plc (NASDAQ: RPRX)
RPRX Technical Analysis
5
As on 9th Jun 2023 RPRX SHARE Price closed @ 32.91 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 41.13 & Strong Sell for SHORT-TERM with Stoploss of 39.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RPRXSHARE Price
Open | 33.90 | Change | Price | % |
High | 33.96 | 1 Day | -1.62 | -4.69 |
Low | 32.82 | 1 Week | 0.17 | 0.52 |
Close | 32.91 | 1 Month | -2.43 | -6.88 |
Volume | 3392600 | 1 Year | -6.31 | -16.09 |
52 Week High 44.65 | 52 Week Low 32.22 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
RPRX Daily Charts |
RPRX Intraday Charts |
Whats New @ Bazaartrend |
RPRX Free Analysis |
|
RPRX Important Levels Intraday
RESISTANCE | 35.11 |
RESISTANCE | 34.40 |
RESISTANCE | 33.97 |
RESISTANCE | 33.53 |
SUPPORT | 32.29 |
SUPPORT | 31.85 |
SUPPORT | 31.42 |
SUPPORT | 30.71 |
RPRX Forecast April 2024
4th UP Forecast | 42.72 |
3rd UP Forecast | 39.57 |
2nd UP Forecast | 37.63 |
1st UP Forecast | 35.68 |
1st DOWN Forecast | 30.14 |
2nd DOWN Forecast | 28.19 |
3rd DOWN Forecast | 26.25 |
4th DOWN Forecast | 23.1 |
RPRX Weekly Forecast
4th UP Forecast | 36.71 |
3rd UP Forecast | 35.49 |
2nd UP Forecast | 34.74 |
1st UP Forecast | 33.98 |
1st DOWN Forecast | 31.84 |
2nd DOWN Forecast | 31.08 |
3rd DOWN Forecast | 30.33 |
4th DOWN Forecast | 29.11 |
RPRX Forecast2024
4th UP Forecast | 57.44 |
3rd UP Forecast | 49.57 |
2nd UP Forecast | 44.71 |
1st UP Forecast | 39.85 |
1st DOWN Forecast | 25.97 |
2nd DOWN Forecast | 21.11 |
3rd DOWN Forecast | 16.25 |
4th DOWN Forecast | 8.38 |
Royalty Pharma plc ( NASDAQ USA Symbol : RPRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RPRX Other Details
Segment | EQ | |
Market Capital | 16311629824.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
RPRX Address
RPRX Latest News
RPRX Business Profile
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 45 marketed therapies and 9 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York. Address: 110 East 59th Street, New York, NY, United States, 10022
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service